Pyrans
eMolecules 5337-03-1 | Tetrahydropyran-4-yl-carboxylic acid | Ambeed | MFCD00031016 | 130.143 | C6H10O3 | 97.000 | OC(=O)C1CCOCC1 | 100g | 552535012
Tetrahydropyran-4-yl-carboxylic acid | Ambeed | 5337-03-1 | MFCD00031016 | 130.143 | C6H10O3 | 97.000 | OC(=O)C1CCOCC1 | 100g | 552535012
eMolecules 40191-32-0 | Tetrahydro-2H-pyran-4-carbonyl chloride | Combi-Blocks | MFCD06200863 | 148.590 | C6H9ClO2 | 97.000 | ClC(=O)C1CCOCC1 | 10g | 249364856
Tetrahydro-2H-pyran-4-carbonyl chloride | Combi-Blocks | 40191-32-0 | MFCD06200863 | 148.590 | C6H9ClO2 | 97.000 | ClC(=O)C1CCOCC1 | 10g | 249364856
eMolecules 33532-46-6 | DIHYDRO-2H-PYRAN-2,4(3H)-DIONE | AstaTech | MFCD24445216 | 114.100 | C5H6O3 | 95.000 | O=C1CCOC(=O)C1 | 1g | 795587766
DIHYDRO-2H-PYRAN-2,4(3H)-DIONE | AstaTech | 33532-46-6 | MFCD24445216 | 114.100 | C5H6O3 | 95.000 | O=C1CCOC(=O)C1 | 1g | 795587766
Medchemexpress LLC Mono-(7-carboxy-4-methylheptyl) phthalate-d4 | 1332966-02-5 | >95.0% | 326.38 | C17H18D4O6 | 500 UG
Mono-(7-carboxy-4-methylheptyl) phthalate-d4 is a deuterium-labeled reference standard of Mono-(7-carboxy-4-methylheptyl) phthalate used primarily as an internal standard in mass spectrometry and other analytical assays. It has chemical formula C17H18D4O6, molecular weight 326.38, and CAS number 1332966-02-5. The material is supplied in small, pre-weighed amounts (for example, 500 μg or 1 mg) and is intended for research use only.
- Deuterium-labeled analog for reliable quantitation in MS assays.
- Pre-weighed small-quantity vials suitable for analytical workflows.
- Appropriate as an internal standard for phthalate metabolite analysis.
- Purity reported greater than 95% for certified reference material variants.
- Intended for research use only.
Medchemexpress LLC Mf-dh-300 | 2673403-86-4 | 99.5% | 330.38 | 50 MG
MF-DH-300 is a 15-PGDH inhibitor that can be used for the research of muscle disorders such as spinal muscular atrophy (SMA). For research use only. 15-PGDH (15-Hydroxyprostaglandin dehydrogenase) acts as a tumor suppressor in various organs (breast, colon, liver, lung, pancreas), with decreased expression linked to increased tumorigenesis. It metabolizes intracellular PGE2, preventing its binding to EP receptors and thereby suppressing PGE2 signaling.
- Applicable to the research of muscle disorders such as spinal muscular atrophy (SMA)
- Inhibits 15-PGDH (15-Hydroxyprostaglandin dehydrogenase)
- Metabolizes intracellular PGE2
- Suppresses PGE2 signaling
eMolecules 110-87-2 | 3,4-Dihydro-2H-pyran | Combi-Blocks | MFCD00006558 | 84.118 | C5H8O | 96.000 | C1COC=CC1 | 5g | 290686712
3,4-Dihydro-2H-pyran | Combi-Blocks | 110-87-2 | MFCD00006558 | 84.118 | C5H8O | 96.000 | C1COC=CC1 | 5g | 290686712
eMolecules 1002127-60-7 | (3,6-Dihydro-2H-pyran-4-yl)-boronic acid | Combi-Blocks, Inc. | MFCD02179502 | 127.930 | C5H9BO3 | 96.000 | OB(O)C1=CCOCC1 | 25g | 869681939
(3,6-Dihydro-2H-pyran-4-yl)-boronic acid | Combi-Blocks, Inc. | 1002127-60-7 | MFCD02179502 | 127.930 | C5H9BO3 | 96.000 | OB(O)C1=CCOCC1 | 25g | 869681939
eMolecules 287944-16-5 | 3,6-Dihydro-2H-pyran-4-boronic Acid Pinacol Ester | Accela ChemBio (ASD) | MFCD11052631 | 210.080 | C11H19BO3 | 97.000 | CC1(C)OB(OC1(C)C)C1=CCOCC1 | 1g | 444759453
3,6-Dihydro-2H-pyran-4-boronic Acid Pinacol Ester | Accela ChemBio (ASD) | 287944-16-5 | MFCD11052631 | 210.080 | C11H19BO3 | 97.000 | CC1(C)OB(OC1(C)C)C1=CCOCC1 | 1g | 444759453
eMolecules 287944-16-5 | 3,6-Dihydro-2H-pyran-4-boronic acid pinacol ester | J & W PharmLab LLC | MFCD11052631 | 210.080 | C11H19BO3 | 96.000 | CC1(C)OB(OC1(C)C)C1=CCOCC1 | 1g | 525294254
3,6-Dihydro-2H-pyran-4-boronic acid pinacol ester | J & W PharmLab LLC | 287944-16-5 | MFCD11052631 | 210.080 | C11H19BO3 | 96.000 | CC1(C)OB(OC1(C)C)C1=CCOCC1 | 1g | 525294254
Medchemexpress LLC MF-DH-300 | 2673403-86-4 | 99.5% | 330.38 | 10 MG
MF-DH-300 is a 15-PGDH inhibitor used for research into muscle disorders such as spinal muscular atrophy (SMA). It targets 15-PGDH (15-Hydroxyprostaglandin dehydrogenase), an enzyme that acts as a tumor suppressor in various organs. By metabolizing intracellular PGE2, this compound suppresses PGE2 signaling, which is implicated in tumorigenesis.
- Used for research into muscle disorders
- Inhibits 15-PGDH
- Acts as a tumor suppressor
- Metabolizes intracellular PGE2
- Suppresses PGE2 signaling
- Applicable to spinal muscular atrophy (SMA) research